Joost A. Aalberse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joost A. Aalberse has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Wilco de Jager
Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
2 shared publications - Aline Sprikkelman
Emma Children's Hospital Academic Medical Centre, Amsterdam, NL Netherlands
1 shared publication - Anders O. J. van Thuijl
Department of Paediatric Respiratory Medicine and Allergy, Emma Children’s Hospital Academic Medical Center, Amsterdam, The Netherlands
1 shared publication Berber Kapitein
Department of Pediatric Immunology, Wilhelmina Children's Hospital, Utrecht, The Netherlands
1 shared publicationBerent J. Prakken
Department of Pediatric Immunology, Wilhelmina Children's Hospital, Utrecht, The Netherlands
1 shared publication- Berent J. Prakken
Department of Pediatrics, Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands
1 shared publication
Latest Publications
- Open Access
- 1 January 2013
- Published by Wiley in Clinical and Translational Allergy
- Vol. 3 (1) , 40
Plasma IL‐25 is elevated in a subgroup of patients with clinical reactivity to peanut
Background: One of the IL‐17 family members, IL‐25, has been implicated with the initiation and amplification of Th2 responses in animal models and has been associated with airway hyper‐reactivity. The involvement of IL‐25 and also IL‐17 in food allergic disease remains to be investigated.Findings: In this study thirty children suspected of peanut allergic disease underwent a double‐blind placebo controlled food challenge (DBPCFC) and IL‐25 and IL‐17 plasma levels were determined before and after challenge. IL‐25 was highly elevated only in subgroup of children with a positive DBPCFC outcome. Plasma IL‐25 was absent in children with a negative DBPCFC outcome and in healthy controls.Conclusions: This study shows that IL‐25, an IL‐17 family member, is highly elevated only in children with a clinical response to peanut. This suggests a role for IL‐25 in the pathogenesis of peanut allergy and elevated plasma IL‐25 may be a sign of a severe atopic phenotype.
- 1 January 2013
- Published by Wiley in Clinical and Translational Allergy
- Vol. 3 (1) , 40
Open AccessPlasma IL‐25 is elevated in a subgroup of patients with clinical reactivity to peanut
Background: One of the IL‐17 family members, IL‐25, has been implicated with the initiation and amplification of Th2 responses in animal models and has been associated with airway hyper‐reactivity. The involvement of IL‐25 and also IL‐17 in food allergic disease remains to be investigated.Findings: In this study thirty children suspected of peanut allergic disease underwent a double‐blind placebo controlled food challenge (DBPCFC) and IL‐25 and IL‐17 plasma levels were determined before and after challenge. IL‐25 was highly elevated only in subgroup of children with a positive DBPCFC outcome. Plasma IL‐25 was absent in children with a negative DBPCFC outcome and in healthy controls.Conclusions: This study shows that IL‐25, an IL‐17 family member, is highly elevated only in children with a clinical response to peanut. This suggests a role for IL‐25 in the pathogenesis of peanut allergy and elevated plasma IL‐25 may be a sign of a severe atopic phenotype.
- Open Access
- 13 September 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9) , e24119
Cord Blood CD4+ T Cells Respond to Self Heat Shock Protein 60 (HSP60)
To prevent harmful autoimmunity most immune responses to self proteins are controlled by central and peripheral tolerance. T cells specific for a limited set of self-proteins such as human heat shock protein 60 (HSP60) may contribute to peripheral tolerance. It is not known whether HSP60-specific T cells are present at birth and thus may play a role in neonatal tolerance. We studied whether self-HSP60 reactive T cells are present in cord blood, and if so, what phenotype these cells have. Cord blood mononuclear cells (CBMC) of healthy, full term neonates (n = 21), were cultured with HSP60 and Tetanus Toxoid (TT) to study antigen specific proliferation, cytokine secretion and up-regulation of surface markers. The functional capacity of HSP60-induced T cells was determined with in vitro suppression assays. Stimulation of CBMC with HSP60 led to CD4+ T cell proliferation and the production of various cytokines, most notably IL-10, Interferon-gamma, and IL-6. HSP60-induced T cells expressed FOXP3 and suppressed effector T cell responses in vitro. Self-reactive HSP60 specific T cells are already present at birth. Upon stimulation with self-HSP60 these cells proliferate, produce cytokines and express FOXP3. These cells function as suppressor cells in vitro and thus they may be involved in the regulation of neonatal immune responses.
- 13 September 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9) , e24119
Open AccessCord Blood CD4+ T Cells Respond to Self Heat Shock Protein 60 (HSP60)
To prevent harmful autoimmunity most immune responses to self proteins are controlled by central and peripheral tolerance. T cells specific for a limited set of self-proteins such as human heat shock protein 60 (HSP60) may contribute to peripheral tolerance. It is not known whether HSP60-specific T cells are present at birth and thus may play a role in neonatal tolerance. We studied whether self-HSP60 reactive T cells are present in cord blood, and if so, what phenotype these cells have. Cord blood mononuclear cells (CBMC) of healthy, full term neonates (n = 21), were cultured with HSP60 and Tetanus Toxoid (TT) to study antigen specific proliferation, cytokine secretion and up-regulation of surface markers. The functional capacity of HSP60-induced T cells was determined with in vitro suppression assays. Stimulation of CBMC with HSP60 led to CD4+ T cell proliferation and the production of various cytokines, most notably IL-10, Interferon-gamma, and IL-6. HSP60-induced T cells expressed FOXP3 and suppressed effector T cell responses in vitro. Self-reactive HSP60 specific T cells are already present at birth. Upon stimulation with self-HSP60 these cells proliferate, produce cytokines and express FOXP3. These cells function as suppressor cells in vitro and thus they may be involved in the regulation of neonatal immune responses.